Cite

HARVARD Citation

    Crowley, V. et al. (2017). Second Generation Grp94‐Selective Inhibitors Provide Opportunities for the Inhibition of Metastatic Cancer. Chemistry. 23 (62), pp. 15775-15782. [Online]. 
  
Back to record